Moneycontrol PRO
HomeAuthorMadhuchanda dey

Madhuchanda Dey

Head Research

Moneycontrol

A soft quarter again, but HCL Tech is running high on stock value

BUSINESS

A soft quarter again, but HCL Tech is running high on stock value

The temporary softness in the stock of HCL Tech after two consecutive quarters has made the valuation enticing, seen in the context of the medium-term growth outlook and the valuation discount to larger peers

Wipro: Turnaround plays out, acceleration unfolding

BUSINESS

Wipro: Turnaround plays out, acceleration unfolding

The positive surprise in Wipro’s Q1FY22 earnings report reiterates the fact that the bold bets of the new CEO and the razor-sharp focus on growth are paying off

Infosys reaps strong demand gains, handles supply challenges smartly

BUSINESS

Infosys reaps strong demand gains, handles supply challenges smartly

We see a strong highway of growth for Infosys and recommend adding the stock on every decline

Mindtree – A great start to FY22

BUSINESS

Mindtree – A great start to FY22

Mindtree is a long-term winner in this technology up-cycle and should be added on every decline

TCS – A soft quarter does not take away the long-term investment case

BUSINESS

TCS – A soft quarter does not take away the long-term investment case

We see strong tailwind for this technology bellwether and this should translate into steady predictable earnings growth. TCS is a core portfolio stock to be added in the current weak phase

What is the true worth of IRCTC?

BUSINESS

What is the true worth of IRCTC?

IRCTC's unique offering of several promising businesses under one umbrella would continue to enjoy a 'scarcity premium'

Can the waning impact of second wave help Ujjivan SFB re-rate?

BUSINESS

Can the waning impact of second wave help Ujjivan SFB re-rate?

High slippage and provision will keep most investors on the sidelines, risk-takers should start looking at the stock of Ujjivan SFB, which is now available at a huge discount to its IPO valuation

Karur Vysya Bank: Valuation deserves a closer look

BUSINESS

Karur Vysya Bank: Valuation deserves a closer look

Karur Vysya Bank's valuation offers downside support

Zensar – A turnaround road map in place

BUSINESS

Zensar – A turnaround road map in place

The upside may be meaningful in Zensar, but it is uncertain and warrants patience. However, the valuation discount makes it a worthy bet for the risk-taker

EaseMyTrip – An outlier in a distressed industry

BUSINESS

EaseMyTrip – An outlier in a distressed industry

The stock of EaseMy Trip should, at the minimum, deliver return mimicking the earnings growth. Further, multiple re-rating remains a possibility for an Internet-based business deriving operating leverage with scale

Can Equitas SFB weather the second wave of the pandemic?

BUSINESS

Can Equitas SFB weather the second wave of the pandemic?

As the situation improves, we expect the stock of Equitas SFB to gradually re-rate

Is there any more upside in Shriram Transport?

BUSINESS

Is there any more upside in Shriram Transport?

Should the market momentum sustain, 35-40 per cent upside is in store for investors in Shriram Transport

M&M Finance promises to go far. This is why

BUSINESS

M&M Finance promises to go far. This is why

Should M&M Finance re-rate to pre-pandemic levels, a meaningful 30 per cent upside is in store in the next one year

Muthoot Finance: Gold financing takes on more shine, stock reasonably priced

BUSINESS

Muthoot Finance: Gold financing takes on more shine, stock reasonably priced

Given the secured and high return ratio business, we see re-rating of Muthoot Finance ahead

Suryoday corrected a lot post listing – Is it time to buy?

BUSINESS

Suryoday corrected a lot post listing – Is it time to buy?

Suryoday SFB is a business which is going through challenges and would revive once the COVID dust settles. We recommend that investors with moderate risk appetite should gradually start adding the stock for the long term

Rising stocks, deadly second wave: What’s happening?

BUSINESS

Rising stocks, deadly second wave: What’s happening?

For Indian equities, the long-term structural liquidity support is hard to ignore and any correction will therefore be short-lived

VIP Industries – Can it retain its numero uno position, post pandemic?

TRENDS

VIP Industries – Can it retain its numero uno position, post pandemic?

While its listed peer has a robust model to withstand near-term down trading, VIP with a complete product range across price points, is ideally positioned to reap the fruits of a complete recovery. Thus any weakness should be used to gradually add this stock for the long term.

Zensar – A high risk bet for the patient investor

TRENDS

Zensar – A high risk bet for the patient investor

While the upside in Zensar may be meaningful, it is uncertain and warrants patience. However, the valuation discount makes it a worthy bet for the risk taker

Mas Financial – Time to add a good business in a soft patch?

BUSINESS

Mas Financial – Time to add a good business in a soft patch?

With the lacklustre performance of the stock, the valuation has corrected to a level that prevailed at the time of its IPO in 2017. The coming weak period of Mas Financial is an opportunity for long-term investors to add the stock

Federal Bank – The cheapest for the quality it offers

BUSINESS

Federal Bank – The cheapest for the quality it offers

Given the challenges in the financial system plagued with asset quality woes and inadequate capital, we see Federal Bank as a long-term winner with its conscious approach to diversify and de-risk the asset book and build a solid deposit base.

Safari – Why the coming weak phase is the best time to add this stock

BUSINESS

Safari – Why the coming weak phase is the best time to add this stock

The long-term macro drivers are in place for Safari despite the temporary disruption

Herd Immunity Part 2: Is the race a sprint or a marathon?

BUSINESS

Herd Immunity Part 2: Is the race a sprint or a marathon?

In terms of Fauci’s estimated threshold (70 percent) for herd immunity, India might reach that goal by mid-November.

Herd Immunity Part 1: Why the markets are not feeling the pain of the second wave

TRENDS

Herd Immunity Part 1: Why the markets are not feeling the pain of the second wave

With markets making a wild swing from despondency to euphoria last year, investors do not want to miss a recovery rally this time around and are exercising patience in the hope of a better second half

Happiest Minds – Can it run more after the stellar rally?

BUSINESS

Happiest Minds – Can it run more after the stellar rally?

We would recommend booking the gains in Happiest Minds and adding the stock on decline in a volatile market.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347